Peijia Medical (HKSE:09996) Total Liabilities : HK$465.8 Mil (As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Peijia Medical Total Liabilities?

Peijia Medical's Total Liabilities for the quarter that ended in Jun. 2024 was HK$465.8 Mil.

Peijia Medical's quarterly Total Liabilities increased from Jun. 2023 (HK$420.27 Mil) to Dec. 2023 (HK$435.20 Mil) and increased from Dec. 2023 (HK$435.20 Mil) to Jun. 2024 (HK$465.84 Mil).

Peijia Medical's annual Total Liabilities increased from Dec. 2021 (HK$176.92 Mil) to Dec. 2022 (HK$758.09 Mil) but then declined from Dec. 2022 (HK$758.09 Mil) to Dec. 2023 (HK$435.20 Mil).

Peijia Medical Total Liabilities Historical Data

The historical data trend for Peijia Medical's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Peijia Medical Total Liabilities Chart

Peijia Medical Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

80.60

176.92

758.09

435.20

687.69

Peijia Medical Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Liabilities	Get a 7-Day Free Trial								758.09	420.27	435.20	465.84	687.69

Peijia Medical Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Peijia Medical's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	168.714	+	(223.92	+	36.558
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	6.005)
	=	435.2

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	2922.538	-	2487.341
	=	435.2

Peijia Medical's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	187.786	+	(236.331	+	35.635
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	6.005)
	=	465.8

Total Liabilities	=	Total Assets (Q: Jun. 2024 )	-	Total Equity (Q: Jun. 2024 )
	=	2814.057	-	2348.214
	=	465.8

Peijia Medical Total Liabilities Related Terms

Thank you for viewing the detailed overview of Peijia Medical's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Peijia Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Peijia Medical Ltd (HKSE:09996) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

8 Zhongtian Street, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN

Website

https://www.peijiamedical.com

Peijia Medical Ltd is focused on the interventional procedural, transcatheter valve therapeutic, and the neurointerventional procedural medical device market in China. The company's product candidates include Transcatheter Aortic Valve Replacement products, Transcatheter Mitral Valve Replacement/Transcatheter Tricuspid Valve Replacement products, Ancillary products, Neurointerventional products, and its product pipeline consists of transcatheter valve therapeutic and neurointerventional products and product candidates. Its operating segments are Transcatheter Valve Therapeutic Business and Neurointerventional Business.

Executives

Pandanus Partners L.p.	2201 Interest of corporation controlled by you
Pandanus Associates Inc.	2201 Interest of corporation controlled by you
Fil Limited	2201 Interest of corporation controlled by you
Hh Sum-xxiv Holdings Limited	2101 Beneficial owner
Hillhouse Investment Management, Ltd.	2102 Investment manager
Hh Imv Holdings, L.p.	2201 Interest of corporation controlled by you
Hillhouse Fund Iv, L.p.	2201 Interest of corporation controlled by you
Zhang Ping Ye	2103 Interests held jointly with another person
Jinnius Drive Trust	2103 Interests held jointly with another person
Xinyue International Limited	2103 Interests held jointly with another person
Ye Hong	2103 Interests held jointly with another person
Hanlindale Trust	2103 Interests held jointly with another person
Zhang Yi	2301 Trustee
Lav Asset Management (hong Kong) Limited	2102 Investment manager
Shi Yi	2201 Interest of corporation controlled by you

Peijia Medical Headlines

No Headlines